Literature DB >> 2194528

Control of mammalian cell proliferation.

A Zetterberg1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2194528     DOI： 10.1016/0955-0674(90)90022-7

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN： 0955-0674            Impact factor:   8.382


× No keyword cloud information.
  6 in total

1.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

2.  Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation.

Authors:  Ho-Joon Lee; Mark P Jedrychowski; Arunachalam Vinayagam; Ning Wu; Ng Shyh-Chang; Yanhui Hu; Chua Min-Wen; Jodene K Moore; John M Asara; Costas A Lyssiotis; Norbert Perrimon; Steven P Gygi; Lewis C Cantley; Marc W Kirschner
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

3.  A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.

Authors:  J M Slingerland; L Hengst; C H Pan; D Alexander; M R Stampfer; S I Reed
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle.

Authors:  R L Marraccino; E J Firpo; J M Roberts
Journal:  Mol Biol Cell       Date:  1992-04       Impact factor: 4.138

5.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

6.  Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.

Authors:  E J Firpo; A Koff; M J Solomon; J M Roberts
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.